440 results
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
What's new in treatment of stent failure - a closer look at stent restenosis and thrombosis
This session shows cases from daily practice that illustrate the problems of stent failure from a general perspective. It allows for a better understanding of the mechanisms of stent restenosis & thrombosis on the one hand, and the role of DCBs on the other.
15-month results of the MASTER DAPT trial
01 Sep 2022
Alex Sticchi provides his take on the final results of the MAnagement of high bleeding risk patients post bioresorbable polymer coated STEnt implantion with an abbReviated versus prolonged DAPT regimen
Author
Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial
30 Aug 2022
The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...
Reviewer
Dealing with complex and unique coronary cases
To gain insight on managing difficult and unusual coronary conditions, view these cases on: balloons, drills and shocks, a novel technique to manage large multiple mycotic aneurysms, rota-stenosis, left main longitudinal compression and many more!
FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial
24 Aug 2022
The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).
Reviewer
Reviewer
